{
    "code": "02022044",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022044",
    "time": "2019-09-06 03:02:52",
    "許可證字號": "衛署藥輸字第022044號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/01\/15",
    "發證日期": "87\/01\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202204409",
    "中文品名": "普樂可復膠囊5毫克",
    "英文品名": "PROGRAF CAPSULES 5MG",
    "適應症": "肝、腎移植之第一線用藥或肝、腎移植CYCLOSPORINE無效之第二線用藥，心臟移植之第二線用藥，心臟移植之第一線用藥。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "TACROLIMUS",
    "主製造廠": {
        "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
        "申請商地址": "台北市中山區民生東路３段１０號５樓",
        "主製造廠": "",
        "製造廠名稱": "FIE0023000  ASTELLAS IRELAND CO., LTD."
    },
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FIE0046000  ASTELLAS PHARMA CO., LIMITED.",
            "製造廠廠址": "",
            "製造廠公司地址": "5 WATERSIDE, CITYWEST BUSINESS CAMPUS, NAAS ROAD,DUBLIN24, IRELAND",
            "製造廠國別": "IRELAND",
            "製程": "製造廠公司"
        },
        {
            "製造廠名稱": "FJP0064300  Astellas Pharma Tech Co., Ltd. Toyama Technology Center",
            "製造廠廠址": "2-178 KOJIN-MACHI, TOYAMA 930-0809 JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "中間體製造"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250000800",
            "成分名稱": "TACROLIMUS",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "PRG 5mg 正反面鋁箔片(Lot no. 5E5002D)-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022044&Seq=433&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Prograf Cap_PRGC-I1812-08_CH-108-05-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022044&Seq=033&Type=9"
        },
        {
            "title": "Prograf Cap 5 mg_carton-107-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022044&Seq=004&Type=8"
        },
        {
            "title": "Prograf Cap 5 mg_carton-106-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022044&Seq=003&Type=8"
        },
        {
            "title": "Prograf Cap 5 mg_blister-106-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022044&Seq=002&Type=8"
        }
    ]
}